2024-04-012025-03-312025-03-31false13062850E RAVINDRAN LTD2025-10-30falseiso4217:GBPxbrli:pure130628502024-03-31130628502025-03-31130628502024-04-012025-03-31130628502023-03-31130628502024-03-31130628502023-04-012024-03-3113062850bus:SmallEntities2024-04-012025-03-3113062850bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113062850bus:FullAccounts2024-04-012025-03-3113062850bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113062850core:WithinOneYear2025-03-3113062850core:AfterOneYear2025-03-3113062850core:WithinOneYear2024-03-3113062850core:AfterOneYear2024-03-3113062850core:ShareCapital2025-03-3113062850core:SharePremium2025-03-3113062850core:RevaluationReserve2025-03-3113062850core:OtherReservesSubtotal2025-03-3113062850core:RetainedEarningsAccumulatedLosses2025-03-3113062850core:ShareCapital2024-03-3113062850core:SharePremium2024-03-3113062850core:RevaluationReserve2024-03-3113062850core:OtherReservesSubtotal2024-03-3113062850core:RetainedEarningsAccumulatedLosses2024-03-3113062850core:LandBuildings2025-03-3113062850core:PlantMachinery2025-03-3113062850core:Vehicles2025-03-3113062850core:FurnitureFittings2025-03-3113062850core:OfficeEquipment2025-03-3113062850core:NetGoodwill2025-03-3113062850core:IntangibleAssetsOtherThanGoodwill2025-03-3113062850core:ListedExchangeTraded2025-03-3113062850core:UnlistedNon-exchangeTraded2025-03-3113062850core:LandBuildings2024-03-3113062850core:PlantMachinery2024-03-3113062850core:Vehicles2024-03-3113062850core:FurnitureFittings2024-03-3113062850core:OfficeEquipment2024-03-3113062850core:NetGoodwill2024-03-3113062850core:IntangibleAssetsOtherThanGoodwill2024-03-3113062850core:ListedExchangeTraded2024-03-3113062850core:UnlistedNon-exchangeTraded2024-03-3113062850core:LandBuildings2024-04-012025-03-3113062850core:PlantMachinery2024-04-012025-03-3113062850core:Vehicles2024-04-012025-03-3113062850core:FurnitureFittings2024-04-012025-03-3113062850core:OfficeEquipment2024-04-012025-03-3113062850core:NetGoodwill2024-04-012025-03-3113062850core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113062850core:ListedExchangeTraded2024-04-012025-03-3113062850core:UnlistedNon-exchangeTraded2024-04-012025-03-3113062850core:MoreThanFiveYears2024-04-012025-03-3113062850core:Non-currentFinancialInstruments2025-03-3113062850core:Non-currentFinancialInstruments2024-03-3113062850dpl:CostSales2024-04-012025-03-3113062850dpl:DistributionCosts2024-04-012025-03-3113062850core:LandBuildings2024-04-012025-03-3113062850core:PlantMachinery2024-04-012025-03-3113062850core:Vehicles2024-04-012025-03-3113062850core:FurnitureFittings2024-04-012025-03-3113062850core:OfficeEquipment2024-04-012025-03-3113062850dpl:AdministrativeExpenses2024-04-012025-03-3113062850core:NetGoodwill2024-04-012025-03-3113062850core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113062850dpl:GroupUndertakings2024-04-012025-03-3113062850dpl:ParticipatingInterests2024-04-012025-03-3113062850dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113062850core:ListedExchangeTraded2024-04-012025-03-3113062850dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113062850core:UnlistedNon-exchangeTraded2024-04-012025-03-3113062850dpl:CostSales2023-04-012024-03-3113062850dpl:DistributionCosts2023-04-012024-03-3113062850core:LandBuildings2023-04-012024-03-3113062850core:PlantMachinery2023-04-012024-03-3113062850core:Vehicles2023-04-012024-03-3113062850core:FurnitureFittings2023-04-012024-03-3113062850core:OfficeEquipment2023-04-012024-03-3113062850dpl:AdministrativeExpenses2023-04-012024-03-3113062850core:NetGoodwill2023-04-012024-03-3113062850core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113062850dpl:GroupUndertakings2023-04-012024-03-3113062850dpl:ParticipatingInterests2023-04-012024-03-3113062850dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113062850core:ListedExchangeTraded2023-04-012024-03-3113062850dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113062850core:UnlistedNon-exchangeTraded2023-04-012024-03-3113062850core:NetGoodwill2025-03-3113062850core:IntangibleAssetsOtherThanGoodwill2025-03-3113062850core:LandBuildings2025-03-3113062850core:PlantMachinery2025-03-3113062850core:Vehicles2025-03-3113062850core:FurnitureFittings2025-03-3113062850core:OfficeEquipment2025-03-3113062850core:AfterOneYear2025-03-3113062850core:WithinOneYear2025-03-3113062850core:ListedExchangeTraded2025-03-3113062850core:UnlistedNon-exchangeTraded2025-03-3113062850core:ShareCapital2025-03-3113062850core:SharePremium2025-03-3113062850core:RevaluationReserve2025-03-3113062850core:OtherReservesSubtotal2025-03-3113062850core:RetainedEarningsAccumulatedLosses2025-03-3113062850core:NetGoodwill2024-03-3113062850core:IntangibleAssetsOtherThanGoodwill2024-03-3113062850core:LandBuildings2024-03-3113062850core:PlantMachinery2024-03-3113062850core:Vehicles2024-03-3113062850core:FurnitureFittings2024-03-3113062850core:OfficeEquipment2024-03-3113062850core:AfterOneYear2024-03-3113062850core:WithinOneYear2024-03-3113062850core:ListedExchangeTraded2024-03-3113062850core:UnlistedNon-exchangeTraded2024-03-3113062850core:ShareCapital2024-03-3113062850core:SharePremium2024-03-3113062850core:RevaluationReserve2024-03-3113062850core:OtherReservesSubtotal2024-03-3113062850core:RetainedEarningsAccumulatedLosses2024-03-3113062850core:NetGoodwill2023-03-3113062850core:IntangibleAssetsOtherThanGoodwill2023-03-3113062850core:LandBuildings2023-03-3113062850core:PlantMachinery2023-03-3113062850core:Vehicles2023-03-3113062850core:FurnitureFittings2023-03-3113062850core:OfficeEquipment2023-03-3113062850core:AfterOneYear2023-03-3113062850core:WithinOneYear2023-03-3113062850core:ListedExchangeTraded2023-03-3113062850core:UnlistedNon-exchangeTraded2023-03-3113062850core:ShareCapital2023-03-3113062850core:SharePremium2023-03-3113062850core:RevaluationReserve2023-03-3113062850core:OtherReservesSubtotal2023-03-3113062850core:RetainedEarningsAccumulatedLosses2023-03-3113062850core:AfterOneYear2024-04-012025-03-3113062850core:WithinOneYear2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113062850core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113062850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113062850core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113062850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113062850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113062850bus:Director12024-04-012025-03-3113062850bus:Director22024-04-012025-03-31

E RAVINDRAN LTD

Registered Number
13062850
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

E RAVINDRAN LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr Eassun Ravindran
Dr Celine Reynolds

Registered Address

3 Monro Place
Epsom
KT19 7LD

Registered Number

13062850 (England and Wales)
E RAVINDRAN LTD
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,4011,492
Investments430,00010,000
31,40111,492
Current assets
Debtors56,95926,436
Cash at bank and on hand151,420135,253
158,379161,689
Creditors amounts falling due within one year6(120,718)(53,507)
Net current assets (liabilities)37,661108,182
Total assets less current liabilities69,062119,674
Provisions for liabilities7(23)(373)
Net assets69,039119,301
Capital and reserves
Called up share capital100100
Profit and loss account68,939119,201
Shareholders' funds69,039119,301
The financial statements were approved and authorised for issue by the Board of Directors on 30 October 2025, and are signed on its behalf by:
Dr Celine Reynolds
Director
Dr Eassun Ravindran
Director

Registered Company No. 13062850
E RAVINDRAN LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carries out during the period. Revenue in respect of dental treatment uncompleted at the year end date us recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 April 243,1503,150
Additions329329
At 31 March 253,4793,479
Depreciation and impairment
At 01 April 241,6581,658
Charge for year420420
At 31 March 252,0782,078
Net book value
At 31 March 251,4011,401
At 31 March 241,4921,492
4.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 April 2410,00010,000
Additions50,00050,000
Disposals(30,000)(30,000)
At 31 March 2530,00030,000
Net book value
At 31 March 2530,00030,000
At 31 March 2410,00010,000

Notes

1Other investments other than loans
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables6,95926,436
Total6,95926,436
6.Creditors: amounts due within one year

2025

2024

££
Taxation and social security30,99748,425
Other creditors87,6843,562
Accrued liabilities and deferred income2,0371,520
Total120,71853,507
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)23373
Total23373
8.Related party transactions
During the year the directors made available a loan to the company of £87,684 (2024: £3,562). Interest has been charged on this balance at the UK market rate. The loan is repayable on demand.